Cathie Wood’s ARK Invest has made some notable moves in its latest stock trades. The investment firm bought shares of Intellia, a biotechnology company focused on gene editing, while selling off its holdings in Tesla. Intellia has been gaining attention for its innovative work in the field of genetic medicine, making it an attractive investment for ARK. On the other hand, ARK decided to part ways with Tesla, a company that has been a longtime favorite in its portfolio. These strategic moves reflect ARK’s commitment to staying ahead of the curve in the ever-evolving world of investing.